City

Bamako (2)

Condition

Hemorrhagic Fever (3)

Ebola Virus Disease (2)

Overall Status

Completed (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

University of Maryland, Baltimore (2)

U.S. Army Medical Research and Development Command (1)

Collaborator

National Institute of Allergy and Infectious Diseases (NIAID) (2)

Leidos Biomedical Research, Inc. (1)

Wellcome Trust (1)

Intervention

booster-mva-bn® filo or saline placebo (1)

ebola chimpanzee adenovirus vector vaccine (cad3-ebo z (1)

mva-ebolaz (1)

placebo (1)

virazole (1)

vrc-eboadc069-00-vp (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

Funder Type

Other (2)

U.S. Fed (1)

Study Type

Interventional (3)

hemorrhagic fever

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hemorrhagic Fever Trial (Virazole)

Not yet recruiting

Hemorrhagic Fever

Virazole

(no location specified)

Jul 20, 2022

Ebola Virus Disease, Hemorrhagic Fever Trial in Bamako (VRC-EBOADC069-00-vp, MVA-EbolaZ, Placebo)

Completed

Ebola Virus Disease
Hemorrhagic Fever

VRC-EBOADC069-00-vp
+2 more

Bamako, Mali

Centre pour le Developpement des Vaccins - Mali

Sep 24, 2019

Ebola Virus Disease, Hemorrhagic Fever Trial in Bamako (Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z, Booster-MVA-BN®

Completed

Ebola Virus Disease
Hemorrhagic Fever

Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO Z
Booster-MVA-BN® Filo or saline placebo

Bamako, Mali

Center for Vaccine Development, Mali

Sep 24, 2019